Tg(Col2a1-rtTA,tetO-cre)22Pjro
Transgene Detail
|
Symbol: |
Tg(Col2a1-rtTA,tetO-cre)22Pjro |
Name: |
transgene insertion 22, Peter J Roughley |
MGI ID: |
MGI:4418267 |
Synonyms: |
COL2-rtTA-Cre, Tg(Col2a1-rtTA-tetO-cre)22Pjro |
Transgene: |
Tg(Col2a1-rtTA,tetO-cre)22Pjro Location: unknown
|
Alliance: |
Tg(Col2a1-rtTA,tetO-cre)22Pjro page
|
|
Strain of Origin: |
Not Specified
|
|
Transgene Type: |
|
Transgenic (Inducible, Recombinase, Transactivator) |
Inducer: |
|
doxycycline/tetracycline |
Mutation: |
|
Insertion
|
|
|
Tg(Col2a1-rtTA,tetO-cre)22Pjro expression driven by
1 gene
Transgene expression driven by:
Organism |
Driver Gene |
Note |
Not Specified |
Col2a1 |
|
|
|
|
Mutation details: The construct was generated such that a 6 kb fragment of the Col2a1 gene (composed of 3 kb of promoter and 3 kb of intron 1 containing an enhancer sequence) controls the reverse tetracycline transactivator sequence. A tetracycline responsive element heptad sequence (tetO) with a CMV minimal promoter is upstream of the cre recombinase coding sequence in this construct. Cre expression can only occur by transactivation of rtTA by doxycycline. The linearized construct was injected into fertilized oocytes and founder mice were obtained (lines 13, 12, 22, and 24). Cre mRNA expression was detected only in cartilage, not in the brain, liver or skin of embryos exposed to doxycycline.
(J:107728)
|
|
|
Activity: |
Tissue activity of this recombinase allele
|
Driver:
|
Col2a1
(species not specified)
|
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:107728 Grover J, et al., Generation of a transgenic mouse in which Cre recombinase is expressed under control of the type II collagen promoter and doxycycline administration. Matrix Biol. 2006 Apr;25(3):158-65 |
All: |
6 reference(s) |
|